Nabriva Therapeutics plc Accounts Payable
Nabriva Therapeutics plc had Accounts Payable of $14.03 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-10-19
- 2023-06-30: Accounts Payable, Current $14.03M.
- 2023-03-31: Accounts Payable, Current $6.98M.
- 2022-12-31: Accounts Payable, Current $5.43M.
- 2022-09-30: Accounts Payable, Current $3.90M.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-06-30 | $14.03M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $6.98M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $5.43M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $3.90M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.58M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.37M 10-K · filed 2023-04-17 |
| 2021-09-30 | $1.48M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.58M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.64M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.89M 10-K · filed 2022-03-29 |
| 2020-09-30 | $2.04M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.62M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.03M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $4.67M 10-K · filed 2021-03-11 |
| 2019-09-30 | $3.22M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.91M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.56M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $3.30M 10-K · filed 2020-03-12 |
| 2018-09-30 | $4.76M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.93M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $3.81M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.14M 10-K · filed 2019-03-12 |
| 2017-09-30 | $5.32M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.32M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.34M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.55M 10-K · filed 2018-03-16 |
| 2015-12-31 | $2.93M 10-K · filed 2017-03-24 |